Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53 , RB1 , and ATRX
Authors:
Open Access
- 31 October 2022
- journal article
- research article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 147 (7) , 817-825
Abstract
Context.—: Epithelioid angiomyolipomas (eAMLs) are rare tumors of the kidney that occur in patients with tuberous sclerosis complex or in a sporadic setting; a subset of these tumors exhibit metastatic behavior. Objective.—: To analyze molecular profiling data to identify pathogenic alterations in rare cases of metastatic eAML, and to identify immunohistochemistry (IHC)-based surrogate markers. Design.—: Molecular profiling data from the American Association for Cancer Research GENIE registry was accessed for 23 patients with angiomyolipomas, and 9 of 16 patients with eAMLs in our institutional registry were evaluated with next-generation sequencing. IHC was performed to screen for alterations of P53, RB, and ATRX for all 16 institutional cases. Results.—: Combined alterations of 5 tumor-suppressor genes (TP53, ATRX, RB1, APC, and NF1) were identified using next-generation sequencing in 7 of 8 (88%) patients with metastatic disease compared to a single patient with nonmetastatic disease (RB1 variant of uncertain significance; 1 of 24, 4%). No cases with abnormal IHC results were identified in 11 patients with nonmetastatic disease compared to 3 of 5 patients with metastatic disease. Conclusions.—: Our results show that the majority of metastatic eAMLs have mutations of 5 tumor-suppressor genes (TP53, ATRX, RB1, APC, and NF1), while these are rare in patients with nonmetastatic disease. Furthermore, IHC for P53, RB, and ATRX may serve as a screen for a subset of these alterations in resource-limited settings. These findings, if validated in larger data sets, have the potential to predict metastatic behavior in eAMLs.Keywords
This publication has 11 references indexed in Scilit:
- Renal Neoplasia in Tuberous Sclerosis: A Study of 41 PatientsMayo Clinic Proceedings, 2021
- Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II TrialJournal of Urology, 2020
- Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell CarcinomaEuropean Urology, 2018
- AACR Project GENIE: Powering Precision Medicine through an International ConsortiumCancer Discovery, 2017
- TFE3 Translocation–associated Perivascular Epithelioid Cell Neoplasm (PEComa) of the Gynecologic TractAmerican Journal of Surgical Pathology, 2015
- Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumorsLaboratory Investigation, 2013
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortalScience Signaling, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Renal Epithelioid Angiomyolipoma With Atypia: A Series of 40 Cases With Emphasis on Clinicopathologic Prognostic Indicators of MalignancyAmerican Journal of Surgical Pathology, 2010
- Malignant Transformation of Renal AngiomyolipomaAmerican Journal of Surgical Pathology, 2002